Strontium-89 (Metastron)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 15:38, 6 August 2019 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

General information

Radioactive strontium

Diseases for which it was used

Prostate cancer

History of changes in FDA indication

6/18/1993: Initial approval

Also known as

Brand name: Metastron

Retrieved from "https://hemonc.org/w/index.php?title=Strontium-89_(Metastron)&oldid=39409"